Research Driven Investing Provides Stocks Research on Chevron and Exxon Mobil Corporation
Continue ReadingTag: analyst-reports
Amyris and Gevo Shares on the Upswing as Environmental Protection Agency Proposes to Raise Renewable Fuels Mandate
Five Star Equities Provides Stock Research on Amyris and Gevo
Continue Reading
FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High
Research Driven Investing Provides Stocks Research on Idenix and Orexigen
Continue Reading
Number of FDA Drug Approvals Reach a 15-Year High in 2012
Research Driven Investing Provides Stocks Research on Cleveland BioLabs and Hyperion Therapeutics
Continue Reading
Interest in Gold as a Safe Haven Increases as GDP Contracts for the First Time in 3.5 Years
Five Star Equities Provides Stock Research on IAMGOLD and New Gold
Continue Reading
BioFuel Energy and Pacific Ethanol on the Move as EPA Proposes to Raise Renewable Fuels Mandate
Five Star Equities Provides Stock Research on BioFuel Energy and Pacific Ethanol
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
Research Driven Investing Provides Stocks Research on Achillion and Galena
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
Research Driven Investing Provides Stocks Research on Cell Therapeutics and Dendreon
Continue Reading
Strong Sales of Marlboro Cigarettes Boosts Altria-s Fourth Quarter Earnings
Research Driven Investing Provides Stocks Research on Altria Group and Philip Morris
Continue Reading
Gold Prices Surge as GDP Shrinks for the First Time in 3 and 1/2 Years
Five Star Equities Provides Stock Research on Gold Fields and Kinross Gold
Continue Reading